MetLife (MET) Form 144 Files Sale; Recent Plan Sales Total 2,628 Shares

Rhea-AI Filing Summary

Form 144 filed for MetLife, Inc. (MET) reports a proposed sale of 64 shares of common stock through Bernstein Institutional Services on 09/19/2025 with an aggregate market value of $5,060.48. The filing states the shares were acquired on 12/17/2019 in a purchase from Bank of America and paid for in cash on 12/19/2019. The issuer has 665,026,054 shares outstanding per the filing. The notice also lists multiple sales by MetLife-related accounts between 06/20/2025 and 07/31/2025, totaling 2,628 shares for gross proceeds of $208,112.38. The filer certifies no undisclosed material adverse information.

Positive

• None.

Negative

• Multiple recent sales by MetLife-related accounts totaling 2,628 shares for $208,112.38 between 06/20/2025 and 07/31/2025
• Form 144 does not state a date of notice in the remarks section

Insights

Securities Analyst

TL;DR: Small insider sale filed; recent related-plan dispositions total 2,628 shares and appear routine, not material to equity base.

The Form 144 notifies a proposed sale of 64 shares valued at $5,060.48, representing an immaterial fraction of the 665,026,054 shares outstanding. The securities were purchased in 2019 from Bank of America and fully paid in cash, reducing questions about contingent consideration. The schedule of prior sales shows institutional/plan-related disposals aggregating 2,628 shares for approximately $208,112.38 from June to July 2025, which are relatively small in absolute and percentage terms versus total outstanding shares. From a market-impact perspective, these transactions are routine disclosures required under Rule 144.

Corporate Governance Expert

TL;DR: Disclosure meets Rule 144 requirements; signatures assert no undisclosed material information.

The filing documents compliance with Rule 144 timing and acquisition details, including original purchase date and payment method. The attestation that the seller is unaware of any material non-public information is standard and required. There is no indication of insider trading plan adoption dates or other trading-plan details in the filing. Given the small size of the proposed sale relative to total shares outstanding, the filing signals routine liquidity activity rather than a governance red flag.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common Stock	Bernstein Institutional Services LLC 245 Park Ave New York NY 10167	64	5060.48	665026054	09/19/2025	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common Stock	12/17/2019	Purchase	BANK OF AMERICA			64	12/19/2019	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
MetLife 401k Plan Trust-Large Cap Equity Index 1 Metlife Way Whippany NJ 07981	Common Stock	06/20/2025	547	43327.87
Separate Account SPI 1 Metlife Way Whippany NJ 07981	Common Stock	06/20/2025	360	28515.6
Separate Account II 1 Metlife Way Whippany NJ 07981	Common Stock	06/20/2025	101	8000.21
Separate Account 149 1 Metlife Way Whippany NJ 07981	Common Stock	06/20/2025	27	2138.67
MetLife 401k Plan Russell 1000 Value 1 Metlife Way Whippany NJ 07981	Common Stock	06/27/2025	1024	82298.88
Separate Account SPI 1 Metlife Way Whippany NJ 07981	Common Stock	07/28/2025	360	27957.6
MetLife 401k Plan Trust-Large Cap Equity Index 1 Metlife Way Whippany NJ 07981	Common Stock	07/31/2025	209	15873.55

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does the Form 144 for MET report?

The filing reports a proposed sale of 64 shares of MetLife common stock through Bernstein Institutional Services on 09/19/2025 with aggregate market value $5,060.48.

When were the shares proposed for sale originally acquired?

The shares were acquired on 12/17/2019 by purchase from Bank of America and paid for in cash on 12/19/2019.

How many MetLife shares are outstanding per the filing?

The filing lists 665,026,054 shares outstanding.

Have there been recent related sales by MetLife accounts?

Yes; the filing lists prior sales from 06/20/2025 to 07/31/2025 totaling 2,628 shares with gross proceeds of $208,112.38.

Does the filer assert knowledge of undisclosed material information?

The filer signs a certification representing they do not know any material adverse information about the issuer that has not been publicly disclosed.